Voyageur Pharmaceuticals Ltd.

VYYRF · OTC
Analyze with AI
11/30/2024
11/30/2023
11/30/2022
11/30/2021
Operating Activities
Net Income-$1,707-$1,399-$1,754-$2,051
Dep. & Amort.$2$2$9$2
Deferred Tax$0$0$6$0
Stock-Based Comp.$467$234$207$738
Change in WC$927$110-$244-$343
Other Non-Cash$9$62$56$0
Operating Cash Flow-$302-$991-$1,719-$1,654
Investing Activities
PP&E Inv.$0-$175-$283-$432
Net Acquisitions$0$0$9$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$166-$175-$283-$438
Investing Cash Flow-$166-$175-$274-$432
Financing Activities
Debt Repay.$0$0-$17-$19
Stock Issued$656$1,200$1,246$2,305
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$24-$63-$18$610
Financing Cash Flow$632$1,136$1,211$2,896
Forex Effect$0$0$0$0
Net Chg. in Cash$163-$29-$781$810
Supplemental Information
Beg. Cash$2$32$813$3
End Cash$166$2$32$813
Free Cash Flow-$302-$991-$2,002-$2,086